Contact A Counsellor

counsellor button


teen suicide icon


panic anxiety icon

panic anxiety icon

#MindfulMondays with Miss SA

teen suicide icon


Research on Depression in the Workplace.

For more information please click here



email subscribers list

To subscribe to SADAG's newsletter, click here

To view previous newsletters - click here


Mental Health Matters Journal for Psychiatrists & GP's

MHM Volume 8 Issue1

Click here for more info


journalists crew making newspaper

If you are a journalist writing a story contact Kayla on 011 234 4837  media@anxiety.org.za


MySchool Facebook banner Nov

It’s the small things that make a BIG difference. Sign up for the “My School | My Village | My Planet” Card and start making a difference to Mental Health in South Africa today.

Click Here


cope with cancer book

Literacy is a luxury that many of us take for granted. That is why SADAG created SPEAKING BOOKS and revolutionized the way healthcare information is delivered to low literacy communities.

The customizable 16-page book, read by local celebrity audio recordings, ensures that vital health and social messages can be seen, heard, read and understood by everyone across the world.

We started with books on Teen Suicide prevention , HIV, AIDS and Depression, Understanding Mental Health and have developed over 100+ titles, such as TB, Malaria, Polio, Vaccines for over 45 countries.

suicide speaking book

An analysis of studies on antipsychotics reveals multiple differences among the newer, second-generation antipsychotics as well as the older medications, and suggests the current classification system blurs important differences, rendering it unhelpful. The analysis, partially funded by NIMH (National Institute for Mental Health), was published online December 5, 2008, in The Lancet.

Stefan Leucht, M.D., of Technische Universität München in Munich, Germany, and colleagues looked at 150 studies from all parts of the world with a total of 21,533 participants. By examining these double-blind studies, they were able to compare nine second-generation—also called atypical—antipsychotics with first-generation antipsychotics. They examined symptom reduction; quality of life; side effects such as movement disorders, weight gain and sedation (sleepiness); and other factors.

Four atypical antipsychotics—amisulpride (Solian), clozapine (Clozaril), olanzapine (Zyprexa) and risperidone (Risperdal)—were found to be more effective in treating overall symptoms of schizophrenia than first-generation medications. The other five studied—aripiprazole (Abilify), quetiapine (Seroquel), sertindole (Serdolect), ziprasidone (Geodon), and zotepine (Nipolept)—were found to be as effective as first-generation medications in treating symptoms of the disease.

Other findings include the following:
· Although quality of life was not reported in most studies, the few that did report it indicated that only amisulpride, clozapine and sertindole improved patients’ quality of life more than first-generation medications.
· All nine atypical antipsychotics caused fewer movement disorders than the first- generation medication haloperidol, which is highly potent. However, when compared with low-potency, first-generation medications such as chlorpromazine and thioridazine, studies showed that only a few atypical medications (clozapine, olanzapine, and risperidone) caused fewer movement disorders, but the low-potency drugs also tended to induce weight gain and sedation like the atypicals. Few studies compared mid-potency first-generation medications, such as perphenazine and sulpiride, to atypicals with regard to movement disorders.
· Amisulpride, clozapine, olanzapine, quetiapine, risperidone, sertindole and zotepine were associated with statistically significantly more weight gain than haloperidol. The researchers found no significant differences in weight gain between the atypicals and the lower-potency, first-generation drugs.
· Clozapine, quetiapine and zotepine were significantly more sedating than haloperidol, while aripiprazole was significantly less sedating than haloperidol.

The researchers conclude that antipsychotics are a heterogeneous group that defies generalization. Leucht and colleagues recommend that clinicians use the data in this report to determine individualized treatment plans for their patients with schizophrenia, keeping in mind effectiveness, side effects and cost of the various antipsychotic medications.


Our Sponsors

Our Partners